Stock Analiz

Faeth Therapeutics, Inc. (FTH) stock forecast and price target

Price $10.03 · data as of November 13, 2026

12-month price target

Average target$56.15
Upside / downside+459.9%
Analysts13
ConsensusStrong buy
Low $40.00Average $56.15High $69.00

Gold marker: average target · white marker: today’s price ($10.03)

Analyst ratings

Strong buy 3Buy 13Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-15.60—$0
Next fiscal year
ends December 31, 2027
$-3.67+76.5%$0
Next quarter
ends December 31, 2026
$-0.88—$0
Quarter after
ends March 31, 2027
$-0.89—$0

Consensus of the analysts covering Faeth Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the Faeth Therapeutics stock price target?

The average 12-month target from 13 analysts is $56.15, 459.9% above the current price of $10.03 Targets range from $40.00 to $69.00.

Is Faeth Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 13 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Faeth Therapeutics expected to earn?

Analysts expect EPS of $-15.60 for the fiscal year ending December 31, 2026 and $-3.67 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.